In the News

Share
1502 News Items found
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
MSK Researchers Discover How Cancer Cells Change Identity To Escape Therapies
Researchers learn how prostate cancer cells change their type to survive treatment.
Feature
A bowl of ginseng root sitting next to a teapot.
Natural Remedies for Dry Mouth (Xerostomia)
Discover some natural remedies for mouth dryness (xerostomia) and mouth sores, common side effects of cancer treatment.
Finding
Two chimpanzees in a field
Cancer Genes in Humans vs. Chimps: Why Are We More Susceptible?
In an unusual collaboration, scientists from MSK and the American Museum of Natural History looked at how the BRCA2 gene differs between humans and chimps. Mutations in this gene are linked to an increased risk of certain cancers, including breast cancer.
Photo of Hispanic patient who had metaplastic breast cancer.
Expertise To Treat Metaplastic Breast Cancer From MSK’s Rare Breast Cancer Program
MSK’s Rare Breast Cancer Program has the expertise needed to treat people with unusual forms of the disease.
MSK breast cancer patient Marcia McFayden seen smiling outdoors.
Living Better During Cancer and Beyond: The MSK Healthy Living Program
Learn about the MSK Healthy Living program that provides breast cancer patients with a custom plan tailored to their needs to help with nutrition and exercise, integrative medicine; support for mental, emotional, and spiritual well-being and much more.
Q&A
physiatrist Jesuel Padro-Guzman
Answers to 8 FAQ About Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
In the Clinic
New Jersey police officer Shad Giacomarro and family
Low-Dose Radiation a Possible 'Game Changer' for Treating HPV-Positive Throat Cancer
An MSK study has shown that HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects.
In the Lab
Scott Lowe
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’
Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
Mini Kamboj, MSK's Chief Medical Epidemiologist
Polio in NY: What You Should Know
Learn what detection of the polio virus in New York State means for you.
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA
The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.